Volume 95 Issue 36 | p. 11 | News of The Week
Issue Date: September 11, 2017 | Web Date: September 6, 2017

Startup sues L’Oreal over anti-aging ingredient

Use of the nucleoside adenosine to erase wrinkles is at the heart of a David versus Goliath dispute
Department: Business
Keywords: Intellectual property, skin care, nucleosides, adenosine

A religious group has filed suit against L’Oreal claiming that the cosmetics giant infringed on patents covering use of the nucleoside adenosine in wrinkle-erasing creams that the charity sells to raise money for the poor. L’Oreal says it did not violate the group’s patents.

According to the suit, filed in Delaware federal court, the Massachusetts-based Teresian Carmelites introduced Easamine, a high-end anti-wrinkle cream containing adenosine, in 2009. Easamine sales were initially strong, say the Teresians, . . .

To view the rest of this content, please log in with your ACS ID.



 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society